# JAVLOR® Online Non-Interventional Trial

> **NCT01103544** · — · COMPLETED · sponsor: **Pierre Fabre Pharma GmbH** · enrollment: 200 (estimated)

## Conditions studied

- Transitional Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01103544
- **Lead sponsor:** Pierre Fabre Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-09
- **Final completion:** 2013-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2015-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103544, "JAVLOR® Online Non-Interventional Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01103544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*